Literature DB >> 10880515

[D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P inhibits bombesin-induced mitogenic signal transduction mediated by both G(q) and G(12) in Swiss 3T3cells.

J Sinnett-Smith1, C Santiskulvong, J Duque, E Rozengurt.   

Abstract

Substance P (SP) analogues including [d-Arg(1),d-Trp(5,7,9), Leu(11)]SP are broad spectrum neuropeptide antagonists and potential anticancer agents, but their mechanism of action is not fully understood. Here, we examined the mechanism of action of [d-Arg(1), d-Trp(5,7,9),Leu(11)]SP as an inhibitor of G protein-coupled receptor (GPCR)-mediated signal transduction and cellular DNA synthesis in Swiss 3T3 cells. Addition of [d-Arg(1),d-Trp(5,7,9), Leu(11)]SP, at 10 micrometer, caused a striking rightward shift in the dose-response curves of DNA synthesis induced by bombesin, bradykinin, or vasopressin and markedly inhibited the activation of p42(mapk) (ERK-2) and p44(mapk) (ERK-1) induced by these GPCR agonists. In addition, this SP analogue also prevented the protein kinase C-dependent activation of protein kinase D induced by these agonists. [d-Arg(1),d-Trp(5,7,9),Leu(11)]SP, at a concentration (10 micrometer) that inhibited these G(q)-mediated events, also prevented GPCR agonist-induced responses mediated through the G proteins of the G(12) subfamily. These include bombesin-induced assembly of focal adhesions, formation of parallel arrays of actin stress fibers, increase in the tyrosine phosphorylation of focal adhesion kinase (FAK), p130(Cas), and paxillin, and formation of a complex between FAK and Src. We conclude that [d-Arg(1),d-Trp(5,7,9),Leu(11)]SP acts as a mitogenic antagonist of neuropeptide GPCRs blocking signal transduction via both G(q) and G(12).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880515     DOI: 10.1074/jbc.M003702200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Involvement of vasodilator-stimulated phosphoprotein in UDP-induced microglial actin aggregation via PKC- and Rho-dependent pathways.

Authors:  Ayako Kataoka; Yui Koga; Ayumi Uesugi; Hidetoshi Tozaki-Saitoh; Makoto Tsuda; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2011-05-13       Impact factor: 3.765

2.  Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.

Authors:  Fang Hao; Qinhong Xu; Yinglan Zhao; Jan V Stevens; Steven H Young; James Sinnett-Smith; Enrique Rozengurt
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

3.  Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.

Authors:  Pei-Wen Chen; Glenn S Kroog
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

4.  The lipid-associated 3D structure of SPA, a broad-spectrum neuropeptide antagonist with anticancer properties.

Authors:  David A Keire; Mohanraja Kumar; Weidong Hu; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

5.  Crosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.

Authors:  Steven H Young; Enrique Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  2010-09-16       Impact factor: 3.575

Review 6.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

Review 7.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

8.  Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.

Authors:  A C MacKinnon; U Tufail-Hanif; C D Lucas; D Jodrell; C Haslett; T Sethi
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

9.  Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.

Authors:  Ming Ming; James Sinnett-Smith; Jia Wang; Heloisa P Soares; Steven H Young; Guido Eibl; Enrique Rozengurt
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.